- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Carl Zeiss MicroImaging GmbH, a leading provider of microscopy solutions for a variety of research, clinical and industrial applications, introduces the LSM 5 EXCITER laser scanning microscope. The LSM 5 EXCITER provides users in the materials research and quality analysis industries with a microscope system that analyzes relatively soft materials like polymers in a non-contact procedure with high measuring accuracy and resolution.
By employing a non-contact confocal technique, users can visualize and measure 2-D and 3-D topographies, determine roughness and waviness, and measure porosity and volume content with a high degree of quality and reliability. Additionally, the possibility of working both in reflected and fluorescent light expands the flexibility of analytical techniques.
The microscope's StitchArt plus option allows for extra-long line profiles or image stack arrays that extend over more than 800 times the size of the scan field to be captured automatically with variable overlapping areas. Numerous other automated processes and adjusting functions are an integral part of the StitchArt plus option as well. These functions include autofocus, automatic contrast and brightness optimization, and the precise, first-order correction of the objective's residual field curvature.
The LSM 5 EXCITER can be precisely tailored to meet each user's specific requirements and can be combined with three different high-end microscopes, including the Axio Imager and Axio Observer microscopes. Additionally, optional Piezo-technology and nanometer scaling allow fast and exact measurements.
About Carl Zeiss MicroImaging GmbH
Carl Zeiss MicroImaging, Inc., a subsidiary of Carl Zeiss, Inc., offers microscopy solutions and systems for research, laboratories, routine and industrial applications. In addition, Carl Zeiss MicroImaging markets microscopy and digital pathology systems for the clinical market, as well as spectral sensors for industrial and pharmaceutical applications. Since1846, Carl Zeiss has remained committed to enabling science and technology to go beyond what man can see. Today, Carl Zeiss is a global leader in the optical and opto-electronic industries. With 11,249 current employees in the Group and offices in over 30 countries, Carl Zeiss is represented in more than 100 countries with production centers in Europe, North America, Central America and Asia. For more information on the breadth of solutions offered by Carl Zeiss MicroImaging, please visit http://www.zeiss.com/micro .
For more information, please click here
Gray & Rice Public Relations
617.367.0100 ext. 146
Copyright © Carl Zeiss MicroImaging GmbHIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
New 'self-healing' gel makes electronics more flexible November 25th, 2015
Scientists design a QKD-based quantum private query with no failure November 25th, 2015
MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015
Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015
Using light-force to study single molecules November 23rd, 2015
Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015
UCLA nanoscientists develop safer, faster way to remove pollutants from water November 23rd, 2015
New EU project designed to link diagnosis and treatment of diseases over the long term: Joint research project aims at the improvement of companion diagnostics and therapy of tumor diseases November 23rd, 2015